Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes.
Altman RK, Parks KA, Schlett CL, Orencole M, Park MY, Truong QA, Deeprasertkul P, Moore SA, Barrett CD, Lewis GD, Das S, Upadhyay GA, Heist EK, Picard MH, Singh JP. Altman RK, et al. Among authors: moore sa. Eur Heart J. 2012 Sep;33(17):2181-8. doi: 10.1093/eurheartj/ehs107. Epub 2012 May 21. Eur Heart J. 2012. PMID: 22613342 Free PMC article.
Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction.
Januzzi JL Jr, Rehman SU, Mohammed AA, Bhardwaj A, Barajas L, Barajas J, Kim HN, Baggish AL, Weiner RB, Chen-Tournoux A, Marshall JE, Moore SA, Carlson WD, Lewis GD, Shin J, Sullivan D, Parks K, Wang TJ, Gregory SA, Uthamalingam S, Semigran MJ. Januzzi JL Jr, et al. Among authors: moore sa. J Am Coll Cardiol. 2011 Oct 25;58(18):1881-9. doi: 10.1016/j.jacc.2011.03.072. J Am Coll Cardiol. 2011. PMID: 22018299 Free article. Clinical Trial.
Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study.
Gaggin HK, Truong QA, Rehman SU, Mohammed AA, Bhardwaj A, Parks KA, Sullivan DA, Chen-Tournoux A, Moore SA, Richards AM, Troughton RW, Lainchbury JG, Weiner RB, Baggish AL, Semigran MJ, Januzzi JL Jr. Gaggin HK, et al. Among authors: moore sa. Congest Heart Fail. 2013 May-Jun;19(3):135-42. doi: 10.1111/chf.12016. Epub 2012 Dec 28. Congest Heart Fail. 2013. PMID: 23279139 Free article. Clinical Trial.
Clinical and Hemodynamic Associations and Prognostic Implications of Ventilatory Efficiency in Patients With Preserved Left Ventricular Systolic Function.
Nayor M, Xanthakis V, Tanguay M, Blodgett JB, Shah RV, Schoenike M, Sbarbaro J, Farrell R, Malhotra R, Houstis NE, Velagaleti RS, Moore SA, Baggish AL, O'Connor GT, Ho JE, Larson MG, Vasan RS, Lewis GD. Nayor M, et al. Among authors: moore sa. Circ Heart Fail. 2020 May;13(5):e006729. doi: 10.1161/CIRCHEARTFAILURE.119.006729. Epub 2020 May 4. Circ Heart Fail. 2020. PMID: 32362167 Free PMC article.
617 results